You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • PO.5.102 Pharmacokinetic modelling of belimumab in patients with lupus nephritis: intravenous and subcutaneous loading dose regimen justification

Article metrics

Article menu

Download PDFPDF

Friday 07 October 2022 from 13:00 to 14:10
PO.5 E- poster session 5: lupus nephritis
PO.5.102 Pharmacokinetic modelling of belimumab in patients with lupus nephritis: intravenous and subcutaneous loading dose regimen justification

 

Online download statistics by month:

Online download statistics by month: September 2022 to March 2024

AbstractFullPdf
Sep 20226008
Oct 202296014
Nov 202243307
Dec 20221907
Jan 202375013
Feb 202386027
Mar 202332016
Apr 20233808
May 20232507
Jun 20231003
Jul 20232307
Aug 20231803
Sep 20232803
Oct 20235607
Nov 20234307
Dec 20234704
Jan 20244704
Feb 20242600
Mar 20244103
Total12030148